Archive for May 2023

Dr Justin Sloane on the Important of Pregnant Women and TDAP Vaccine Why Should Pregnant Women Be Vaccinated? Many women may not realize that they are not up-to-date on their immunizations and are susceptible to diseases that can harm them or their unborn child. Pregnant women should talk to their doctors to figure out which…

Part 3: Like training for a marathon, Olympic medalist Molly Seidel knows her mental health is something she can work on every day. https://www.webmd.com/add-adhd/video/default.htm

When it comes to menopause, many women seek relief from unwanted symptoms like hot flashes, night sweats, and sleep problems. Experts warn that alcohol use can make these symptoms even worse. Mayo Clinic’s Dr. Juliana Kling says limiting alcohol use during menopause may not only help ease your symptoms, but it may also help lower…

Please be advised that this video contains graphic footage of surgery. On 07-08-2022, the Case Records of the Mayo Clinic Florida Neurosurgery presented an endoscopic transhpenoidal approach  for a tumor resection.

On 07-22-2022, the Case Records of the Mayo Clinic Florida Neurosurgery presented “Outcomes in epilepsy surgery in the older population: not too old, not too late” by Dr. Robih Singh

Please be advised that this video contains graphic footage of surgery. On 07-08-2022, the Case Records of the Mayo Clinic Florida Neurosurgery presented an endoscopic transhphenoidal approach for a tumor resection.

On 07-22-2022, the Case Records of the Mayo Clinic Florida Neurosurgery presented “Time to and rate of fusion in long segment ACDF” by Dr. Jesse McClure.

Exercise Is Even Better in Nature, Research Says Take exercise outside to nature if you want greater benefits, including mental clarity and motivation, new research into “green exercise” suggests. One study, published in Nature, says the neurological effects of physical activity in nature include better working memory and concentration. College students performed better after outdoor…

CME Course Overview video

An experimental drug for Alzheimer’s disease shows promise to slow the progression of the disease, according to clinical trial results reported by Eli Lilly and Company. Study participants with mild cognitive impairment or mild dementia stages of Alzheimer’s disease who received donanemab showed a slowing of clinical decline by 35% compared to placebo and resulted…